Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bartolucci P et al. – No significant between–group differences were observed for the primary outcome or the secondary end points. Thus, although ketoprofen was well–tolerated, it had no significant efficacy as treatment of VOC requiring hospitalization. These findings argue against its systematic use in this setting.

Related Articles

Pandemic Influenza as 21st Century Urban Public Health Crisis
Emerging Infectious Diseases, 12/01/09    Relevance Score: 40%

Contrast Echocardiography and Migraine in Divers with Patent Foramen Ovale
Canadian Journal of Neurological Sciences, 11/25/09    Relevance Score: 40%

Impact of the Economic Crisis and Increase in Food Prices on Child Mortality: Exploring Nutritional Pathways
The Journal of Nutrition, 11/20/09    Relevance Score: 40%

Are You Ready to Respond to a Public Health Crisis
AMN Healthcare, 11/03/09    Relevance Score: 40%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address